TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30299359

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftazidime/avibactam
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ceftolozane/tazobactam and ceftazidime/avibactam
Number of subjects: 0
Study: 27596353

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 2 mg/kg Q3W
Number of subjects: 520

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 10 mg/kg Q3W
Number of subjects: 520

Group type: COMPARATOR
Intervention: Chemotherapy (control)
Number of subjects: 520
Study: 24735005

Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.4% (n=37), administered 4 times daily for 3 days before surgery and 5 weeks postoperatively.
Number of subjects: 81

Group type: COMPARATOR
Intervention: Hypromellose/dextran 70 as a placebo (n=44), administered 4 times daily for 3 days before surgery and 5 weeks postoperatively.
Number of subjects: 81
Study: 22153864

Group type: EXPERIMENTAL
Intervention: Conjunctival Autograft (CAU)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Conjunctival-Limbal Autograft (CLAU)
Number of subjects: 87
Study: 20064211

Group type: EXPERIMENTAL
Intervention: CAT-354 (1 mg/kg, 5 mg/kg, or 10 mg/kg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 18330081

Group type: EXPERIMENTAL
Intervention: Liposomal doxorubicin (40 mg/m2) administered intravenously at 4 week intervals
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Liposomal doxorubicin
Number of subjects: 22
Study: 15677736

Group type: EXPERIMENTAL
Intervention: Resistance training (12‐wk progressive resistance training program of the knee extensor muscles)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no training)
Number of subjects: 8
Study: 11923242

Group type: EXPERIMENTAL
Intervention: Medium-Dk RGP lenses (Dk of 49)
Number of subjects: 42

Group type: COMPARATOR
Intervention: High-Dk RGP lenses (Dk of 92)
Number of subjects: 42
Study: 9862051

Group type: EXPERIMENTAL
Intervention: 5-day etoposide phosphate (EP)
Number of subjects: 29

Group type: COMPARATOR
Intervention: 15-day etoposide phosphate (EP)
Number of subjects: 29
Study: 7603889

Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg/day)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 31617768

Group type: EXPERIMENTAL
Intervention: Driving simulator training (EXP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: On-road training (CMP)
Number of subjects: 32
Study: 30194492

Group type: EXPERIMENTAL
Intervention: BRN-01 homeopathic medicine complex (Actheane®)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study: 29716492

Group type: EXPERIMENTAL
Intervention: Continuous infusion of 0.2% ropivacaine via adductor canal catheter for five days
Number of subjects: 86

Group type: COMPARATOR
Intervention: Continuous infusion of 0.2% ropivacaine via adductor canal catheter for three days
Number of subjects: 86
Study: 26988768

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg.kg(‐1) body mass plus 0.1 g.kg(‐1) body mass sodium chloride)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.3 g.kg(‐1) body mass)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.3 g.kg(‐1) body mass) plus caffeine (5 mg.kg(‐1) body mass)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (0.1 g.kg(‐1) body mass sodium chloride)
Number of subjects: 13
Study: 24531987

Group type: EXPERIMENTAL
Intervention: Adolescents with 8 or more friends
Number of subjects: 10578

Group type: COMPARATOR
Intervention: Adolescents with 0-1 friends
Number of subjects: 10578

Group type: EXPERIMENTAL
Intervention: Comparison of adolescents with higher peer status vs. lower peer status
Number of subjects: 10578

Group type: COMPARATOR
Intervention: Socially disengaged adolescents
Number of subjects: 10578
Study: 22528506

Group type: EXPERIMENTAL
Intervention: Metoprolol formulations (100 mg) - slow, moderate, and fast releasing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral solution (50 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthetic solution method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral solution data
Number of subjects: 0
Study: 19040679

Group type: EXPERIMENTAL
Intervention: Divalproex sodium extended-release (initiated at 500 mg/day for 15 days, then increased to 1000 mg daily, with adjustments permitted within a dosing range of 250-1000 mg daily)
Number of subjects: 241

Group type: EXPERIMENTAL
Intervention: Divalproex sodium extended-release
Number of subjects: 241
Study: 16500701

Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention for teachers to recognize symptoms of clinical depression
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (no training before reporting)
Number of subjects: 151
Study: 15312855

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 1,200 mg orally twice daily; NAC group; n = 97
Number of subjects: 192

Group type: COMPARATOR
Intervention: Fenoldopam 0.10 microg/kg/min; fenoldopam group; n = 95
Number of subjects: 192
Study: 11564104

Group type: EXPERIMENTAL
Intervention: Brånemark two‐stage (submerged) system (BRS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: ITI one‐stage (non‐submerged) system (ITI)
Number of subjects: 40
Study: 9692411

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg twice daily until delivery)
Number of subjects: 283

Group type: COMPARATOR
Intervention: No treatment (nifedipine given if diastolic pressure exceeded 110 mmHg)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 283

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 283
Study: 7820978

Group type: EXPERIMENTAL
Intervention: MgSO4 infusion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 12
Study: 3349009

Group type: EXPERIMENTAL
Intervention: Carteolol 2%
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Timolol 0.5%
Number of subjects: 6

Group type: COMPARATOR
Intervention: Dummy eyedrops
Number of subjects: 6
Study: 31642350

Group type: EXPERIMENTAL
Intervention: TPB measured in alternate-order
Number of subjects: 770

Group type: COMPARATOR
Intervention: TPB measured in ensemble-order
Number of subjects: 770
Study: 29496602

Group type: EXPERIMENTAL
Intervention: Multiple media (TV and Internet) condition
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Single media (TV) condition
Number of subjects: 160
Study: 27349416

Group type: EXPERIMENTAL
Intervention: Dynamic Pruritus Score (DPS)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Visual Analogue Scale (VAS)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Health status questionnaires (EuroQol; EQ-5D)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Skin-related quality of life (Dermatology Life Quality Index; DLQI)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Anxiety and depression (Hospital Anxiety and Depression Scale; HADS)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Patient Benefit Index (PBI)
Number of subjects: 81
Study: 26108426

Group type: EXPERIMENTAL
Intervention: Nanofilled FRCs after oven postcuring
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional FRCs after hand light-curing
Number of subjects: 80

Group type: COMPARATOR
Intervention: 0.6-mm FRCs
Number of subjects: 80
Study: 24035531

Group type: EXPERIMENTAL
Intervention: BCI-C (Breast-Cancer Index - Cubic)
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: BCI-L (Breast-Cancer Index - Linear)
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: 21-gene recurrence score
Number of subjects: 665

Group type: EXPERIMENTAL
Intervention: IHC4
Number of subjects: 665
Study: 20734082

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 515
Study: 18171334

Group type: EXPERIMENTAL
Intervention: Intramuscular antivenom (one or two vials)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intravenous antivenom (one vial or two or more vials)
Number of subjects: 20
Study: 16879942

Group type: EXPERIMENTAL
Intervention: 150 ml, 240 mg/ml at 4 ml/s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 120 ml, 300 mg/ml at 4 ml/s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 97.3 ml, 370 mg/ml at 4 ml/s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 150 ml, 240 mg/ml at 5 ml/s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 120 ml, 300 mg/ml, 60 ml at 6 ml/s, 60 ml at 3 ml/s
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 97.3 ml, 370 mg/ml at 3.3 ml/s
Number of subjects: 120

Group type: COMPARATOR
Intervention: Constant iodine administration rates (groups II, IV and VI)
Number of subjects: 120
Study: 12807165

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation powder (Pulmicort Turbuhaler), 100-800 microg b.i.d. for 52 weeks
Number of subjects: 1133

Group type: EXPERIMENTAL
Intervention: Budesonide inhalation powder (Pulmicort Turbuhaler)
Number of subjects: 1133
Study: 10890303

Group type: EXPERIMENTAL
Intervention: Enough Snuff self-help manual and a video
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: LifeSign, a credit card-sized computer designed for gradual ST cessation
Number of subjects: 198
Study: 8888715

Group type: EXPERIMENTAL
Intervention: Telenzepine (M1‐muscarinic receptor antagonist)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 1891575

Group type: EXPERIMENTAL
Intervention: Psychodynamic, time-limited group therapy
Number of subjects: 46
Study: 6846235

Group type: EXPERIMENTAL
Intervention: Se-rich wheat (200 micrograms Se/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Se-rich yeast (200 micrograms Se/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sodium selenate (200 micrograms Se/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (unsupplemented subjects, N=20)
Number of subjects: 30
Study: 30245148

Group type: EXPERIMENTAL
Intervention: Eribulin plus cyclophosphamide (ErC)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Docetaxel plus cyclophosphamide (TC)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Both ErC and TC
Number of subjects: 76
Study: 30131266

Group type: EXPERIMENTAL
Intervention: Structure (S) condition
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Book metaphor (BM) condition
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Post organizer (PO) condition
Number of subjects: 127

Group type: COMPARATOR
Intervention: Natural conversation (NC) condition
Number of subjects: 127
Study: 28531784

Group type: EXPERIMENTAL
Intervention: BB (Barley kernel bread)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: BB-pro (Barley kernel bread with probiotics)
Number of subjects: 21

Group type: COMPARATOR
Intervention: WWB-ref (White wheat flour based bread)
Number of subjects: 21
Study: 24667038

Group type: EXPERIMENTAL
Intervention: Femtosecond laser in situ keratomileusis (FS-LASIK) with a side-cut angle of 115°
Number of subjects: 48

Group type: COMPARATOR
Intervention: Femtosecond laser in situ keratomileusis (FS-LASIK) with a side-cut angle of 70°
Number of subjects: 48
Study: 23005039

Group type: EXPERIMENTAL
Intervention: Melatonin (1 mg)
Number of subjects: 21
Study: 20521324

Group type: EXPERIMENTAL
Intervention: Lorazepam (acute dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17908851

Group type: EXPERIMENTAL
Intervention: Low-speed handpiece with prophylaxis angles
Number of subjects: 20
Study: 15611488

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 135

Group type: COMPARATOR
Intervention: Placebo (mock transcutaneous electrical stimulation)
Number of subjects: 135
Study: 9714995

Group type: EXPERIMENTAL
Intervention: Methyldopa
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (Normal Pregnancy)
Number of subjects: 30
Study: 8038589

Group type: EXPERIMENTAL
Intervention: Double perfusion schedule with melphalan (6 mg/l limb volume for first perfusion, 9 mg/l for second perfusion, normothermic, 1 hour duration, 3-4 weeks interval)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Single perfusion procedure with melphalan (10 mg/l, normothermic, 1 hour duration)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Double perfusion schedule
Number of subjects: 87

Group type: COMPARATOR
Intervention: Single perfusion procedure
Number of subjects: 87
Study: 2498532

Group type: EXPERIMENTAL
Intervention: Intravesical mitomycin C (40 mg)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (conventional follow-up)
Number of subjects: 43
Study: 949902

Group type: EXPERIMENTAL
Intervention: gefarnate (600 mg daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: dummy treatment
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: gefarnate
Number of subjects: 32
Study: 30531772

Group type: EXPERIMENTAL
Intervention: Venarus and compression therapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Compression therapy alone
Number of subjects: 100
Study: 27317972

Group type: EXPERIMENTAL
Intervention: Mushroom-substituted carne asada
Number of subjects: 147

Group type: COMPARATOR
Intervention: Taco blend recipes with full sodium
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Mushroom-containing recipes
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Reduced-sodium recipes
Number of subjects: 147

Group type: COMPARATOR
Intervention: Full-sodium recipes
Number of subjects: 147
Study: 24956066

Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control training (ACT)
Number of subjects: 0
Study: 22531825

Group type: EXPERIMENTAL
Intervention: Anatomical decomposition of movement (elbow flexion/extension and unified shoulder motion)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Euler decomposition of movement (three component shoulder motions in Euler coordinates and elbow flexion/extension)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Visual decomposition of movement (motion of the tip of the elbow and motion of the hand with respect to the elbow)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group practicing the target motion only
Number of subjects: 3
Study: 19737089

Group type: EXPERIMENTAL
Intervention: PHD inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ischemic or hypoxic preconditioning
Number of subjects: 0
Study: 18712455

Group type: COMPARATOR
Intervention: Standard intramedullary femoral instruments (IM group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: New extramedullary device (EM group)
Number of subjects: 100
Study: 15933281

Group type: EXPERIMENTAL
Intervention: Behavioral treatment implemented three times per week for 20 to 30 min each session for 3 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Behavioral treatment
Number of subjects: 20
Study: 12783289

Group type: EXPERIMENTAL
Intervention: Ibandronate (2 or 4 mg)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Pamidronate (15, 30, 60, or 90 mg)
Number of subjects: 72
Study: 10943910

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (non-competitive NMDA antagonist)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8669652

Group type: EXPERIMENTAL
Intervention: Rocuronium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atracurium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 0
Study: 1644724

Group type: EXPERIMENTAL
Intervention: Nortriptyline (not specified dosage or duration)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 12
Study: 6131825

Group type: EXPERIMENTAL
Intervention: Quazepam 15 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Quazepam 30 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 1 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All active drugs (Quazepam and Flunitrazepam)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: All drugs tested (Quazepam and Flunitrazepam)
Number of subjects: 100
Study: 31638878

Group type: EXPERIMENTAL
Intervention: Mobile texting aftercare intervention (Project ESQYIR)
Number of subjects: 80
Study: 30922973

Group type: EXPERIMENTAL
Intervention: SomaScan Assay (SomaLogic) measuring 1305 proteins in serum and urine
Number of subjects: 60
Study: 29227735

Group type: EXPERIMENTAL
Intervention: Running + plyometric group (RPG)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Running group (RG)
Number of subjects: 25
Study: 27000058

Group type: EXPERIMENTAL
Intervention: Diet + Think Slim intervention (n=67)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Diet-only control group (n=67)
Number of subjects: 134
Study: 25218717

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Decaffeinated coffee (DECAF)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Caffeine (CAF)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Caffeine with decaffeinated coffee (COF)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: All treatments (PLA, DECAF, CAF, COF)
Number of subjects: 12
Study: 21835151

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 1520

Group type: COMPARATOR
Intervention: Optimal Pharmacologic Therapy (OPT)
Number of subjects: 1520
Study: 21142736

Group type: EXPERIMENTAL
Intervention: 810-nm diode laser treatment
Number of subjects: 35
Study: 18097896

Group type: EXPERIMENTAL
Intervention: Intramuscular ergometrine (500 microg) during abdominal closure
Number of subjects: 50

Group type: COMPARATOR
Intervention: Routine bolus dose of 5 units of oxytocin after delivery
Number of subjects: 50
Study: 15650888

Group type: EXPERIMENTAL
Intervention: Walking at different speeds (0.5 to 1.7 m/s) with loads from 0 to 75% of body mass
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Walking at optimal speed of 1.3 m/s with a load up to 1/4 M(b)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Walking at optimal speed of 1.06 m/s for net cost minimization
Number of subjects: 10
Study: 12170143

Group type: EXPERIMENTAL
Intervention: Intravenous MgSO(4) with carbogen inhalation
Number of subjects: 133

Group type: COMPARATOR
Intervention: Carbogen inhalation
Number of subjects: 133
Study: 10458241

Group type: EXPERIMENTAL
Intervention: vincristine, carmustine, melphalan, cyclophosphamide, and prednisone
Number of subjects: 101

Group type: COMPARATOR
Intervention: melphalan and prednisone
Number of subjects: 101
Study: 7853039

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 2893560

Group type: EXPERIMENTAL
Intervention: Epidural sufentanil 50 micrograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular buprenorphine 0.3 mg
Number of subjects: 0
Study: 29536107

Group type: EXPERIMENTAL
Intervention: Didactic training plus video simulation (N = 43)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Didactic training (N = 51)
Number of subjects: 94
Study: 27105893

Group type: EXPERIMENTAL
Intervention: Video dubbed by the surgeon
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Silent video
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 129
Study: 24012322

Group type: EXPERIMENTAL
Intervention: Real LTE RF‐EMF exposure for 30 minutes
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham exposure (control)
Number of subjects: 18
Study: 22492277

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 450

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 450
Study: 19464064

Group type: EXPERIMENTAL
Intervention: Bosentan 62.5 mg bid for four weeks (uptitrated to 125 mg bid thereafter)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Bosentan
Number of subjects: 54
Study: 18413309

Group type: EXPERIMENTAL
Intervention: Diabetes in patients with preserved EF
Number of subjects: 7599

Group type: EXPERIMENTAL
Intervention: Diabetes in patients with low EF
Number of subjects: 7599

Group type: COMPARATOR
Intervention: Candesartan treatment
Number of subjects: 7599
Study: 20054085

Group type: EXPERIMENTAL
Intervention: Live cows (Group A)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Breed'n Betsy (Group B)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Live cows (intense training, Experiment 2)
Number of subjects: 27
Study: 15901290

Group type: EXPERIMENTAL
Intervention: Levovist 1 g
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sono Vue 1 mL
Number of subjects: 40
Study: 11323581

Group type: EXPERIMENTAL
Intervention: Sandwich method (ligation-sclerotherapy-ligation)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Ligation alone
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Sandwich method
Number of subjects: 94
Study: 9395700

Group type: EXPERIMENTAL
Intervention: Qigong therapy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Therapeutic touch (TT) therapy
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (nonbelievers)
Number of subjects: 44
Study: 8388479

Group type: EXPERIMENTAL
Intervention: All-trans-retinoic acid (all-trans-RA) at a dose of 156 mg/m2 on day 28 and 78 mg/m2 on day 29.
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: All-trans-retinoic acid (all-trans-RA) at a dose of 78 mg/m2 on day 28 and 156 mg/m2 on day 29.
Number of subjects: 6
Study: 2445783

Group type: EXPERIMENTAL
Intervention: Postrotation experimental group (curriculum in developmental pediatrics)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Prerotation control group (no curriculum in developmental pediatrics)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Subjective evaluations by residents and faculty preceptors
Number of subjects: 161
Study: 11449752

Group type: EXPERIMENTAL
Intervention: Family-involved treatments
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Al-Anon facilitation and referral
Number of subjects: 36

Group type: COMPARATOR
Intervention: Johnson intervention
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Community Reinforcement and Family Training
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Behavioral Couples Therapy (BCT)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Disulfiram contract procedure
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Family systems and family disease approaches
Number of subjects: 36